Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2855852/0/en/Cognition-Therapeutics-to-Present-at-the-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/04/01/2855103/0/en/Cognition-Therapeutics-to-host-Virtual-KOL-Event-on-the-Evolving-Landscape-in-Alzheimer-s-Disease-on-April-12-2024.html
https://www.globenewswire.com/news-release/2024/03/26/2852233/0/en/Cognition-Therapeutics-Reports-Year-End-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/03/15/2846980/0/en/Cognition-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2023-Results.html
https://www.globenewswire.com//news-release/2024/03/14/2846694/0/en/Cognition-Therapeutics-Announces-Closing-of-11-5-Million-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/03/12/2844241/0/en/Cognition-Therapeutics-Announces-Pricing-of-11-5-Million-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/03/11/2844153/0/en/Cognition-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/03/06/2841289/0/en/Cognition-Therapeutics-Presents-Analyses-at-AD-PD-2024-Correlating-Proteomic-Findings-with-Treatment-Effect-of-CT1812-in-Alzheimer-s-Disease-Studies.html
https://www.globenewswire.com//news-release/2024/02/26/2835044/0/en/Cognition-Therapeutics-to-Present-at-the-TD-Cowen-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824357/0/en/New-Publication-Identifies-Key-Proteins-Involved-in-Amyloid-Oligomer-Binding-and-Supports-Mechanism-of-CT1812.html